Skinfold Thickness as a Cardiometabolic Risk Predictor in Sedentary and Active Adult Populations. [PDF]
J Pers Med, 2023 González-Torres S +5 more
europepmc +1 more source
Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial. [PDF]
Foods, 2022 Silva-Adame MB +4 more
europepmc +1 more source
Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials. [PDF]
Ther Clin Risk Manag, 2021 Muñoz-Villegas P +4 more
europepmc +1 more source
Patients' Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation. [PDF]
Patient Prefer Adherence, 2022 Costa Gil JE +13 more
europepmc +1 more source
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER. [PDF]
BMC Endocr Disord, 2022 Arnold SV +10 more
europepmc +1 more source
[Prospective observational study of the impact of problems accessing treatment such as risk factors for adherence and persistence. Pilot study]. [PDF]
Farm Comunitarios, 2023 Jaraiz Magariños I +5 more
europepmc +1 more source
Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers. [PDF]
BMC Pharmacol Toxicol, 2019 Méndez-Sánchez N +4 more
europepmc +1 more source
[Biological and biosimilar drugs: Clarifying concepts]. [PDF]
Aten Primaria, 2018 Rodriguez Cumplido D, Asensio Ostos C.
europepmc +1 more source
Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization. [PDF]
Biomed Res Int, 2015 Miranda-Hernández MP +10 more
europepmc +1 more source
Review on transdermal patches: optimization in drug administration. [PDF]
Colomb Med (Cali)Sarmiento Giraldo JJ +3 more
europepmc +1 more source